2m 2m 2m 2m 2m 2m 2m
INDIVIOR PHARMA (INDV)
NASDAQ
$36.05+$0.67 (+1.89%)
Price as of Oct 02, 2026 6:25 PM EDT- $4.2BMarket Cap
- 52.11%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INDIVIOR PHARMA (INDV)
$36.05+$0.67 (+1.89%)
INDV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.38 | ||
Change | -$0.47 (-1.31%) | ||
Open | $35.85 | ||
High | $36.20 | ||
Low | $35.25 | ||
Previous Close | $35.85 | ||
Volume | 1,879,040 | ||
30-Day Average Volume | 2,040,102 | ||
1-Week Change | -1.72% | ||
1-Month Change | 2.37% | ||
1-Year Change | 52.11% | ||
3-Year Change | 53.36% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 118.0M | ||
Total Assets | $1.2B | ||
Market Cap | $4.2B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $343.0M | ||
Net Income | $122.0M | ||
Free Cash Flow | $222.0M | ||
EBIT | $160.0M | ||
EBITDA | $162.0M | ||
Net Working Capital | -$143.0M | ||
EPS | $0.98 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -20 | ||
P/E | 36 | ||
PEG | 1 | ||
Price/Free Cash Flow | 19 | ||
Price/Operating Cash Flow | 18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 10/30/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue